Further studies are necessary to ascertain whether differentially modulating ACKR3 is essential and/or beneficial when targeting ACKR3-related diseases including cardiovascular diseases (as atherosclerosis)85, autoimmune diseases (as multiple sclerosis)86,87, and cancer64,88. This evidence concerns the gene ACKR3 and cardiovascular disorder.